Evidence for higher proportion of "little" growth hormone with increased radioreceptor activity in acromegalic plasma
- PMID: 950368
- DOI: 10.1210/jcem-43-2-364
Evidence for higher proportion of "little" growth hormone with increased radioreceptor activity in acromegalic plasma
Abstract
Plasma growth hormone (GH) from both normal and acromegalic patients comprises multiple immunoreactive components that can be separated by G-100 Sephadex gel filtration and measured by radioimmunoassay (RIA) and radioreceptor assay (RRA). The higher molecular weight immunoreactive components, from both normal and acromegalic subjects, have a lower RRA/RIA than does the lower molecular weight "little" GH component. The "little" GH component comprises a higher proportion of the total immunoreactive GH in acromegalic plasma than in normal plasma whether the data are expressed only in terms of the "big" and "little" components (89 vs. 71%), or as a function of total immunoreactive GH (76 vs. 55%), or whether the plasma is obtained in the basal or stimulated state for the acromegalic patients. When the RRA/RIA x 100 is determined for the isolated "little" component, the acromegalic has a significantly greater ratio than the normal (110 vs. 75%). We conclude that acromegalic plasma contains a higher proportion of the more radioreceptor active "little" GH component than does the normal and, in addition, that the "little" component from the acromegalic is more radioreceptor-active than the normal.
Similar articles
-
"Big" growth hormone components from human plasma: decreased reactivity demonstrated by radioreceptor assay.Science. 1973 Nov 23;182(4114):829-31. doi: 10.1126/science.182.4114.829. Science. 1973. PMID: 4746491
-
Increased circulating radioreceptor-active growth hormone in insulin-dependent diabetics.Clin Endocrinol (Oxf). 1986 Nov;25(5):607-16. doi: 10.1111/j.1365-2265.1986.tb03615.x. Clin Endocrinol (Oxf). 1986. PMID: 3621625
-
Size heterogeneity of circulating growth hormone in acromegaly. "Big-big" GH forms are associated with inappropriately low IGF-I levels.Acta Endocrinol (Copenh). 1991 Aug;125(2):150-9. doi: 10.1530/acta.0.1250150. Acta Endocrinol (Copenh). 1991. PMID: 1897332
-
Human growth hormone. Characterization of plasma and pituitary components and application of a new radioreceptor assay.Isr J Med Sci. 1974 Oct;10(10):1239-46. Isr J Med Sci. 1974. PMID: 4140167 Review. No abstract available.
-
Measuring growth hormone activity through receptor and binding protein assays.Horm Res. 1991;36 Suppl 1:21-6. doi: 10.1159/000182183. Horm Res. 1991. PMID: 1806479 Review.
Cited by
-
Identification and characterization of specific binding proteins for growth hormone in normal human sera.J Clin Invest. 1986 Jun;77(6):1817-23. doi: 10.1172/JCI112507. J Clin Invest. 1986. PMID: 3711337 Free PMC article.
-
Bromocriptine in the treatment of acromegaly.Drugs. 1979 May;17(5):359-64. doi: 10.2165/00003495-197917050-00005. Drugs. 1979. PMID: 378651 Review. No abstract available.
-
Unusual heterogeneity of circulating prolactin in an acromegalic.J Endocrinol Invest. 1981 Apr-Jun;4(2):221-7. doi: 10.1007/BF03350457. J Endocrinol Invest. 1981. PMID: 6792266
-
Expression of two human growth hormone genes in monkey cells infected by simian virus 40 recombinants.Proc Natl Acad Sci U S A. 1981 Dec;78(12):7398-402. doi: 10.1073/pnas.78.12.7398. Proc Natl Acad Sci U S A. 1981. PMID: 6174972 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources